COSMOS Financial Statements From 2010 to 2025
COSMOS Pharmaceutical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing COSMOS Pharmaceutical's valuation are provided below:COSMOS Pharmaceutical does not now have any fundamental signals for analysis.
This module can also supplement various COSMOS Pharmaceutical Technical models . Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private.
Check COSMOS Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among COSMOS Pharmaceutical's main balance sheet or income statement drivers, such as , as well as many indicators such as . COSMOS financial statements analysis is a perfect complement when working with COSMOS Pharmaceutical Valuation or Volatility modules.
COSMOS |
COSMOS Pharmaceutical Company Operating Margin Analysis
COSMOS Pharmaceutical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current COSMOS Pharmaceutical Operating Margin | 0.04 % |
Most of COSMOS Pharmaceutical's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, COSMOS Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, COSMOS Pharmaceutical has an Operating Margin of 0.0383%. This is 100.11% lower than that of the Healthcare sector and significantly higher than that of the Pharmaceutical Retailers industry. The operating margin for all United States stocks is 100.7% lower than that of the firm.
COSMOS Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining COSMOS Pharmaceutical's current stock value. Our valuation model uses many indicators to compare COSMOS Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across COSMOS Pharmaceutical competition to find correlations between indicators driving COSMOS Pharmaceutical's intrinsic value. More Info.COSMOS Pharmaceutical is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.43 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for COSMOS Pharmaceutical is roughly 2.34 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the COSMOS Pharmaceutical's earnings, one of the primary drivers of an investment's value.Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in COSMOS Pink Sheet
If you are still planning to invest in COSMOS Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the COSMOS Pharmaceutical's history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |